Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Larimar Therapeutics, Inc. LRMR

Healthcare  —  Biotechnology
3.87 0.05 1.31% as of 23 Sep
Market cap
$396.8M
P/E
0.0×
Insider Buys (last 12m)
Insider Buys alert about insiders buying in the last 12 month
Overview Business Profile Analyst Commentary Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K
Quarterly (Descending) Quarterly (Ascending) Annual (Descending) Annual (Ascending) TTM (Descending) TTM (Ascending)
Download Excel — free account
Dec '25 Dec '24 Dec '23 Dec '22 Jan '22 Dec '21 Jan '21 Dec '20 Jan '20 Dec '19
Quick Ratio 2.11 7.53 9.13 11.06 11.06 7.92 7.95 10.30 10.31 0.21
Current Ratio 2.19 8.02 9.49 11.28 11.28 8.16 8.16 10.89 10.89 0.81
Net Debt/EBITDA 0.79 1.91 2.00 3.20 3.13 1.40 1.29 2.17 2.03 (0.32)
Debt/Assets 0.00% 0.00% 0.00% 0.00% 3.79% 0.00% 6.87% 0.00% 5.73% 162.74%
Debt/Equity 0.00 0.00 0.00 0.00 0.04 0.00 0.08 0.00 0.07 (12.20)
Asset Turnover 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating CF/Net income 0.68 0.88 0.91 0.78 0.78 0.83 0.83 0.99 0.99 0.98
Capex/Depreciation 0.07 0.10 0.11 0.22 0.00 (1.07) 0.00 (0.38) 0.00 (1.06)
Depreciation/Fixed assets (2.17) (5.60) (2.24) (0.55) 0.07 0.30 0.07 0.16 0.03 0.28
Interest Coverage 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
ROE (132.59%) (63.58%) (38.36%) (31.88%) (40.33%) (78.61%) (65.72%) (47.36%) (95.47%) 3,333.14%
ROA (95.75%) (54.43%) (33.24%) (27.97%) (34.48%) (64.37%) (55.23%) (40.58%) (77.32%) (444.76%)
ROIC 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% (214.59%)
Cash ROIC (52.96%) (20.17%) (20.26%) (12.38%) (13.35%) (32.08%) (33.28%) (23.71%) (25.05%) (261.68%)
Return on Tangible Assets (212.81%) (46.91%) (45.42%) (31.89%) (31.09%) (78.62%) (74.67%) (47.20%) (45.22%) 2,655.80%
Accounts Receivable Turnover — — — — — — 0.00 — 0.00 0.00
Accounts Payable Turnover 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Inventory Turnover — — — — 0.00 — 0.00 — 0.00 —
Average Days of Receivables — — — — — — 0.00 — 0.00 0.00
Average Days of Payables 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days of Inventory on Hand — — — — 0.00 — 0.00 — 0.00 —
Research and Development Expense of Revenue 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Selling, General and Administrative Expense of Revenue 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Intangible Assets out of Total Assets 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Share Based Compensation of Revenue 0.00% 0.00% 0.00% 0.00% — 0.00% — 0.00% — 0.00%
Revenue per Share 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating CF per Share (1.55) (1.16) (0.76) (1.07) (1.07) (2.45) (2.45) (3.55) (3.55) (3.73)
Capex per Share 0.00 (0.01) 0.00 0.00 0.00 (0.02) 0.00 (0.01) 0.00 (0.01)
Free Cash Flow per Share (1.55) (1.16) (0.77) (1.07) (1.07) (2.47) (2.45) (3.56) (3.55) (3.74)
Cash per Share 1.88 2.99 1.98 4.60 4.60 4.08 4.08 7.80 7.80 0.17
Shareholders Equity per Share 1.07 2.80 1.86 4.31 4.31 3.75 3.75 7.55 7.55 (0.11)
Interest Debt per Share 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Book value per Share 1.07 2.80 1.86 4.31 4.31 3.75 3.75 7.55 7.55 (0.11)
Free Cash Flow (113.29) (71.27) (33.62) (27.67) (27.57) (42.44) (42.10) (42.26) (42.21) (22.78)
Working Capital 77.23 170.95 80.67 110.03 110.03 63.36 63.36 88.96 88.96 (1.14)
Capital Expenditures (0.09) (0.51) (0.16) (0.10) (0.10) (0.33) (0.33) (0.06) (0.06) (0.08)
Net Current Asset Value 74.27 166.89 75.96 105.24 105.24 57.95 57.95 82.96 82.96 (1.14)
Average Receivables — — — — — — 0.12 — 0.14 0.37
Average Payables 3.82 1.85 1.48 1.69 1.67 1.66 2.15 2.63 3.09 3.54
Average Assets 173.03 148.08 111.17 126.41 102.54 78.67 91.68 104.69 54.94 5.20
Average Common Equity 124.95 126.77 96.31 110.90 87.66 64.41 77.05 89.69 44.50 (0.69)
Capex to Sales 0.00 0.00 0.00 0.00 — 0.00 — 0.00 — 0.00
Net Profit Margin 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Columns are period end dates